Helping individuals with opioid use disorders and mental illness reduce overdose and suicide risks
Reducing Overdose and Suicide Risk in Individuals with OUD and Co-occurring Disorders
This study is looking to help people with opioid use disorders and mental health challenges by finding better ways to support them after they visit the emergency room, making sure they can easily get the treatment they need to stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11112489 on NIH RePORTER |
What this research studies
This research focuses on addressing the critical issue of overdose and suicide among individuals with opioid use disorders (OUD) and co-occurring mental health conditions. It aims to enhance access to medications for opioid use disorder (MOUD) and improve the transition from emergency department care to outpatient treatment. By utilizing the California Bridge Program, the research will explore effective strategies to ensure patients receive ongoing support and treatment after their initial emergency visit. The study will analyze patient data to identify barriers to treatment adherence and develop tailored interventions to meet diverse patient needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing opioid use disorders and have co-occurring mental health conditions.
Not a fit: Patients who do not have opioid use disorders or co-occurring mental health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of overdose and suicide among individuals struggling with opioid use disorders and mental health issues.
How similar studies have performed: Previous research has shown success in improving treatment outcomes for patients with opioid use disorders through similar intervention strategies, indicating a promising approach.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Watkins, Katherine E — Rand Corporation
- Study coordinator: Watkins, Katherine E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.